L. Varanasi

发表

Mutant p53 cooperates with ETS2 to promote etoposide resistance.

I. Kubacka, P. M. Do, L. Varanasi, 2012, Genes & development.

Subunit III-depleted cytochrome c oxidase provides insight into the process of proton uptake by proteins.

L. Varanasi, J. Hosler, 2012, Biochimica et biophysica acta.

Altering conserved lipid binding sites in cytochrome c oxidase of Rhodobacter sphaeroides perturbs the interaction between subunits I and III and promotes suicide inactivation of the enzyme.

L. Varanasi, D. Mills, J. Hosler, 2006, Biochemistry.

Effects of Ginger Phenylpropanoids and Quercetin on Nrf2-ARE Pathway in Human BJ Fibroblasts and HaCaT Keratinocytes

L. Varanasi, P. Džubák, J. Hlaváč, 2016, BioMed research international.

Rad18 is a transcriptional target of E2F3

P. M. Do, L. Varanasi, Luis A. Martinez, 2012, Cell cycle.

A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis

P. Meltzer, S. Ambs, S. Bilke, 2014, Oncogene.

Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells.

L. Varanasi, P. Džubák, P. Moudry, 2017, Journal of proteomics.

Affinity-based methods in drug-target discovery.

L. Varanasi, P. Džubák, J. Hlaváč, 2015, Current drug targets.

Frequency of chromosome 17 polysomy in relation to CEP17 copy number in a large breast cancer cohort

L. Varanasi, Z. Kolár̂, S. Doněvská, 2016, Genes, chromosomes & cancer.

Alternative initial proton acceptors for the D pathway of Rhodobacter sphaeroides cytochrome c oxidase.

L. Varanasi, J. Hosler, 2011, Biochemistry.

Subunit III-depleted cytochrome c oxidase provides insight into the process of proton uptake by proteins.

L. Varanasi, J. Hosler, 2012, Biochimica et biophysica acta.